in this issue
Markets :: Specialty Chemicals :: Water treatment
Ashland beats estimates despite lower sales, confirms water treatment sale
November 5, 2013 | Vincent Valk
Ashland today reported fiscal fourth-quarter net income from continuing operations of $404 million, or $5.13/share, compared with a $272-million net loss in the year-ago quarter. One-time gains, particularly an actuarial gain on pensions, added $283 million, or $3.59/share, to fourth-quarter results. Excluding these gains, adjusted earnings totaled $1.54/share, beating analysts’ consensus estimate of $1.50/share, as reported by Thomson Reuters. Sales declined 7% year-on-year (YOY), to $1.9 billion. Ashland’s fiscal fourth-quarter ended on 30...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee